Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care.
Multidisciplinary team (MDT) meetings are becoming the model of care for cancer patients worldwide. While MDTs have improved the quality of cancer care, the meetings impose substantial time pressure on the members, who generally attend several such MDTs. We describe Lung Cancer Assistant (LCA), a cl...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Royal Society of London
2014
|
| _version_ | 1797065908337770496 |
|---|---|
| author | Sesen, M Peake, MD Banares-Alcantara, R Tse, D Kadir, T Stanley, R Gleeson, F Brady, M |
| author_facet | Sesen, M Peake, MD Banares-Alcantara, R Tse, D Kadir, T Stanley, R Gleeson, F Brady, M |
| author_sort | Sesen, M |
| collection | OXFORD |
| description | Multidisciplinary team (MDT) meetings are becoming the model of care for cancer patients worldwide. While MDTs have improved the quality of cancer care, the meetings impose substantial time pressure on the members, who generally attend several such MDTs. We describe Lung Cancer Assistant (LCA), a clinical decision support (CDS) prototype designed to assist the experts in the treatment selection decisions in the lung cancer MDTs. A novel feature of LCA is its ability to provide rule-based and probabilistic decision support within a single platform. The guideline-based CDS is based on clinical guideline rules, while the probabilistic CDS is based on a Bayesian network trained on the English Lung Cancer Audit Database (LUCADA). We assess rule-based and probabilistic recommendations based on their concordances with the treatments recorded in LUCADA. Our results reveal that the guideline rule-based recommendations perform well in simulating the recorded treatments with exact and partial concordance rates of 0.57 and 0.79, respectively. On the other hand, the exact and partial concordance rates achieved with probabilistic results are relatively poorer with 0.27 and 0.76. However, probabilistic decision support fulfils a complementary role in providing accurate survival estimations. Compared to recorded treatments, both CDS approaches promote higher resection rates and multimodality treatments. |
| first_indexed | 2024-03-06T21:35:02Z |
| format | Journal article |
| id | oxford-uuid:45f42c16-5804-4152-8cf4-2aba84975f76 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:35:02Z |
| publishDate | 2014 |
| publisher | Royal Society of London |
| record_format | dspace |
| spelling | oxford-uuid:45f42c16-5804-4152-8cf4-2aba84975f762022-03-26T15:10:52ZLung Cancer Assistant: a hybrid clinical decision support application for lung cancer care.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:45f42c16-5804-4152-8cf4-2aba84975f76EnglishSymplectic Elements at OxfordRoyal Society of London2014Sesen, MPeake, MDBanares-Alcantara, RTse, DKadir, TStanley, RGleeson, FBrady, MMultidisciplinary team (MDT) meetings are becoming the model of care for cancer patients worldwide. While MDTs have improved the quality of cancer care, the meetings impose substantial time pressure on the members, who generally attend several such MDTs. We describe Lung Cancer Assistant (LCA), a clinical decision support (CDS) prototype designed to assist the experts in the treatment selection decisions in the lung cancer MDTs. A novel feature of LCA is its ability to provide rule-based and probabilistic decision support within a single platform. The guideline-based CDS is based on clinical guideline rules, while the probabilistic CDS is based on a Bayesian network trained on the English Lung Cancer Audit Database (LUCADA). We assess rule-based and probabilistic recommendations based on their concordances with the treatments recorded in LUCADA. Our results reveal that the guideline rule-based recommendations perform well in simulating the recorded treatments with exact and partial concordance rates of 0.57 and 0.79, respectively. On the other hand, the exact and partial concordance rates achieved with probabilistic results are relatively poorer with 0.27 and 0.76. However, probabilistic decision support fulfils a complementary role in providing accurate survival estimations. Compared to recorded treatments, both CDS approaches promote higher resection rates and multimodality treatments. |
| spellingShingle | Sesen, M Peake, MD Banares-Alcantara, R Tse, D Kadir, T Stanley, R Gleeson, F Brady, M Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care. |
| title | Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care. |
| title_full | Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care. |
| title_fullStr | Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care. |
| title_full_unstemmed | Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care. |
| title_short | Lung Cancer Assistant: a hybrid clinical decision support application for lung cancer care. |
| title_sort | lung cancer assistant a hybrid clinical decision support application for lung cancer care |
| work_keys_str_mv | AT sesenm lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare AT peakemd lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare AT banaresalcantarar lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare AT tsed lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare AT kadirt lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare AT stanleyr lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare AT gleesonf lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare AT bradym lungcancerassistantahybridclinicaldecisionsupportapplicationforlungcancercare |